Each of the founding technical members of Cloaked Therapeutics is a recognized and experienced leader in drug discovery and development.
James D. McChesney, Ph.D. has more than 50 years of experience in natural products chemistry and more than 25 years of experience in drug discovery and development. He conceived and implemented the National Center for Natural Products Research on the Ole Miss campus; developed an economic commercial process for paclitaxel production from cultivated Taxus biomass; and designed and developed a next generation taxane (TPI 287) currently in Phase II clinical trials.
Steve J. Bannister, Ph.D. has 30 years of experience applying the fundamentals of physical and analytical chemistry to the design, development, and characterization of drug delivery systems.
Lisa McChesney-Harris, Ph.D. is formally trained in pharmaceutical chemistry and has over 22 years of experience spanning every aspect of pharmaceutical drug development, from preformulation through A/NDA submission and FDA interactions.
Sam L. Nguyen, Ph.D., JD, has over 15 years of pharmaceutical research with international pharmaceutical companies and over 15 years of practice as a patent attorney.
Jonas V. Alsenas, DVM, who serves as our strategic consultant has over 25 years of experience as a biotechnology industry analyst, executive and consultant.
Michael A Hawotte, President of The Staghorn Group, Inc., a Management Consulting and Forensic Investigations company.